ArticleThe Journal of dermatology2026
A Prediction Model for the Differential Diagnosis of Bowen's Disease and Bowenoid Actinic Keratosis.
Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bowen's disease and bowenoid actinic keratosis share overlapping clinical and histopathological features, and there is no clear consensus regarding their differential diagnosis. This study aimed to identify clinicopathological differences between the two diseases and to develop a diagnostic prediction model in a Korean population. We retrospectively analyzed 253 patients pathologically diagnosed with Bowen's disease or bowenoid actinic keratosis at a single institution in South Korea. Clinical and histopathological variables were compared between the two groups, and significant variables were incorporated into a multivariable logistic regression model. The model was externally validated using an independent cohort of 207 patients from another institution in South Korea. In the development cohort, variables significantly associated with diagnosis included lesion location, adjacent pigmented lesions, solar elastosis, pathologically identical lesions in the same region, and the number of atypical cells within a 3 mm width of the epidermis. The prediction model showed good discriminative performance, with an area under the receiver operating characteristic curve of 0.897. In the external validation cohort, the model demonstrated excellent performance, with an area under the curve of 0.994 and an accuracy of 95.17%. These findings suggest that integration of clinical and histopathological features may help differentiate Bowen's disease from bowenoid actinic keratosis in Korean clinical settings. Further validation in ethnically and geographically diverse populations is needed before broader application of the proposed model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.